Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NQO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TKT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHTOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMP24-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TUBA1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERP29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on